Kyoto, Japan

Takane Katayama

USPTO Granted Patents = 9 



Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Kasugai, JP (2000)
  • Ishikawa, JP (2008 - 2018)
  • Kyoto, JP (2005 - 2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Takane Katayama

Introduction

Takane Katayama is a prominent inventor based in Kyoto, Japan. With a total of 9 patents to his name, he has made significant contributions to the fields of biotechnology and medical research. His work focuses on developing innovative solutions that address critical health challenges.

Latest Patents

Among his latest patents is a co-culture device for anaerobic bacterium and epithelial cells. This culture system allows for the co-culturing of different cell groups under anaerobic conditions, facilitating advanced research in cellular interactions. Another notable patent is an oral cancer vaccine that can be administered orally. This vaccine utilizes a transformed cell capable of expressing and displaying a WT1 protein, making it applicable to patients with various HLA types.

Career Highlights

Throughout his career, Takane Katayama has worked with esteemed organizations such as Ajinomoto Co., Ltd. and Kobe University. His experience in these institutions has allowed him to refine his research and contribute to groundbreaking innovations in the medical field.

Collaborations

Takane has collaborated with notable colleagues, including Hidehiko Kumagai and Hideyuki Suzuki. These partnerships have further enhanced his research capabilities and expanded the impact of his inventions.

Conclusion

Takane Katayama's innovative work in biotechnology and medical research exemplifies the importance of creativity and collaboration in addressing health challenges. His contributions continue to pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…